RenovoRx Q1 2026 Earnings EPS Miss as PreRevenue Biotech Continues Clinical Development USFD Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher Commercecom Inc Series 1 CMRC Q1 2026 Earnings EPS Beat Drives Positive Market Reaction POSCO Holdings PKX Q4 2025 Earnings Significant EPS Miss Driven by Negative Surprise Smith Nephew SNN Q4 2014 Earnings Narrow EPS Beat Fails to Lift Shares